ICD-10 code G35.D: Multiple sclerosis, unspecified

Key Takeaways

ICD-10 code G35.D (Multiple sclerosis, unspecified) is a billable FY2026 code effective October 1, 2025, replacing the former catch-all code G35.

G35.D applies when the MS type or disease course is not documented or not yet established; use a more specific sibling code when the clinician has confirmed RRMS, PPMS, or SPMS.

Always report companion manifestation codes alongside G35.D when clinically present: spasticity (R25.2), bladder dysfunction (N31.-), or vision disorders (H53-H54).

Pabau’s claims management software streamlines G35.D claim submission and tracks ERA responses so neurology billing teams can catch denials before they age.

Multiple sclerosis coding changed significantly on October 1, 2025. The single code G35 that covered every MS diagnosis for decades was retired in the FY2026 ICD-10-CM update and replaced by a family of condition-specific subcodes. ICD-10 code G35.D now represents Multiple sclerosis, unspecified, and using it incorrectly on a claim risks a denial that stalls prior authorization for disease-modifying therapy. Understanding the full medical billing workflow for G35.D is now table stakes for any neurology practice or coding team. This reference covers the code definition, the complete FY2026 sibling code set, documentation requirements, manifestation coding, MS-DRG mapping, and practical EHR update steps.

ICD-10 code G35.D: definition, billability, and FY2026 details

ICD-10 code G35.D describes Multiple sclerosis, unspecified. It is a billable, specific ICD-10-CM code, meaning it can be submitted directly to payers for reimbursement without requiring a more granular subcode. The CDC’s ICD-10-CM tool confirms G35.D became effective October 1, 2025, as part of the FY2026 code cycle. “MS NOS” (not otherwise specified) is an acceptable approximate synonym recognized within the tabular list.

G35.D sits within the G35-G37 demyelinating disease block of ICD-10-CM, under the broader G00-G99 diseases of the nervous system chapter. Its parent category is G35, the former general Multiple sclerosis code that it now replaces for unspecified presentations.

Why G35.D replaced the old G35 code in FY2026

For years, G35 functioned as a single catch-all diagnosis code covering every presentation of multiple sclerosis. A neurologist documenting relapsing-remitting MS used G35. So did one documenting primary progressive MS. The code gave payers no clinical detail about disease course or MS type.

The CMS FY2026 ICD-10-CM update retired G35 as a standalone billable code and expanded it into a family of subcategory codes. Each subcode corresponds to a recognized MS disease course, with G35.D capturing the residual “unspecified” category when the treating clinician has not yet documented a specific MS type. Per the ICD-10 diagnostic code expansion pattern CMS has applied across other neurological conditions, the goal is more clinically precise documentation that supports value-based care models and improves payer adjudication accuracy.

The full family of new multiple sclerosis ICD-10 codes for FY2026

The FY2026 update introduced the most significant expansion of MS-specific ICD-10-CM codes to date, according to the CMS FY2026 addenda. Six codes now sit under the G35 parent, each targeting a distinct MS disease course or clinical scenario.

Coders should treat G35.D as the default only when the medical record genuinely does not support a more specific subcode. The AAPC ICD-10-CM code reference notes that G35.D is new for FY2026 and explicitly replaces the former G35 code for unspecified presentations.

When to use ICD-10 code G35.D vs other multiple sclerosis codes

G35.D is appropriate when a confirmed MS diagnosis is present but the clinician has not documented a specific disease course. This happens most often at initial diagnosis, when the treating neurologist is still observing the clinical pattern, or when the patient transfers care and prior records are incomplete.

Using G35.D when a specific course is documented and supportable is a coding error. Payers processing prior authorization for disease-modifying therapies such as natalizumab or ocrelizumab increasingly require the MS subtype in the diagnosis code. G35.D on a PA submission for a PPMS-specific therapy will often trigger a medical necessity review. Review the guidance on neurological ICD-10 documentation for broader context on how specificity affects claim outcomes in this code block.

Documentation requirements for G35.D

Submitting G35.D without adequate medical record support is an audit risk. ICD-10-CM Official Guidelines require that the code selection reflect what the clinician has documented, not what the coder infers. For G35.D specifically, the record must establish three things.

• Confirmed MS diagnosis: The treating neurologist (or MS specialist) must have documented a definitive diagnosis of multiple sclerosis, not a suspected or rule-out presentation.
• Rationale for unspecified type: The record should reflect why a specific disease course is not coded, such as early presentation, insufficient observation period, or pending further workup.
• Clinician attestation: For inpatient claims, the attending physician’s query response or attestation must be present in the record. For outpatient claims, the encounter note itself must support the code.

Good ICD-10 diagnostic code expansion practice means updating EHR note templates to include a structured field for MS disease course. When neurologists document the course at every encounter, coders rarely need to fall back to G35.D after the initial visits.

The CDC ICD-10-CM tabular list instructs coders to report additional codes when certain MS manifestations are clinically present. These companion codes give payers a complete picture of the patient’s disease burden and support medical necessity for associated treatments. Omitting them when they are documented is a missed coding opportunity that can affect reimbursement accuracy.

Manifestation coding also matters for ICD-10 codes for comorbid conditions that commonly accompany MS, such as depression or anxiety. These are not listed as “use additional code” items in the G35.D tabular entry, but coding them when documented is correct ICD-10-CM practice and supports a more complete clinical picture for payers and care coordinators.

Excludes notes and coding restrictions for ICD-10 code G35.D

The G35-G37 demyelinating disease block carries no Excludes1 notes that directly affect G35.D. Coders should verify the FY2026 tabular list for any Excludes2 notes that may apply in specific clinical scenarios, particularly when documenting MS alongside other demyelinating conditions such as Devic’s disease (neuromyelitis optica) or acute disseminated encephalomyelitis (ADEM), which sit in adjacent code ranges and must not be coded together with G35.D when the documentation reflects a distinct separate condition rather than MS manifestation.

Per standard ICD-10-CM sequencing rules, G35.D functions as a principal or secondary diagnosis depending on the encounter type. In outpatient settings, code the condition chiefly responsible for the visit. In inpatient settings, follow the Uniform Hospital Discharge Data Set guidelines for principal diagnosis selection.

MS-DRG mapping for G35.D and reimbursement context

For inpatient claims, G35.D maps to MS-DRG v43.0 under the FY2026 CMS definitions manual. The specific DRG assignment depends on the presence of complications or comorbidities (CC) or major complications or comorbidities (MCC). Coders and case managers should verify the exact DRG numbers against the CMS MS-DRG v43.0 Definitions Manual published at cms.gov, as DRG weights and payment rates are updated annually and citing specific dollar amounts without a current FY2026 CMS source is not recommended practice.

Submitting G35.D claims electronically through a clearinghouse that validates ICD-10-CM codes against current payer edits significantly reduces rejection risk. Electronic claims submission via Claim.MD, Pabau’s integrated clearinghouse partner, includes built-in ICD-10-CM and CPT code catalogues that flag non-billable or incorrect codes before transmission. The claims management software surfaces real-time payer edits so billing teams correct G35.D sequencing or manifestation-code gaps before the claim reaches the payer. After adjudication, electronic remittance advice (ERA) data flows back automatically, letting teams reconcile G35.D-related payments against expected reimbursement without manual 835 file parsing.

Impact on prior authorization and insurance claims

Payer PA systems have been updated to recognize the FY2026 G35.D code in place of the retired G35. Most major commercial insurers now require one of the specific G35.x subcodes when processing PA for disease-modifying therapies. Submitting G35.D (unspecified) for a drug with a labeled indication tied to a specific MS type, such as ocrelizumab for PPMS, will often trigger an automated medical necessity review or denial.

Billing teams should note three practical workflow adjustments.

• Pre-submission eligibility check: Verify that G35.D is accepted by the payer for the specific service being billed before submission. PA criteria vary by payer and plan; there is no universal rule.
• Denial tracking by code: Flag G35.D denials separately from specific-subcode denials in your denial log. If G35.D generates a higher denial rate than G35.1x, the problem is upstream in documentation, not billing. Systematic managing of claim denials by ICD-10 code is the fastest way to identify documentation gaps driving avoidable write-offs.
• Clean claim validation: Ensure every G35.D submission meets clean claim submission requirements before the file reaches the clearinghouse. Common failure points include missing manifestation codes and incorrect sequencing when G35.D is used as a secondary diagnosis.

Streamline G35.D billing from documentation to payment

Pabau connects EHR documentation, claim submission, and ERA reconciliation in one platform. See how neurology and specialty practices use Pabau to reduce coding errors and accelerate reimbursement.

Book a demo

How to update your EHR and billing templates for ICD-10 code G35.D

Coding teams and neurologists who previously relied on a G35 “favorites list” shortcut need to act before legacy templates generate incorrect codes. Most EHR systems do not auto-update diagnosis picklists when CMS publishes new codes. This is the content gap no competitor article addresses directly: the practical steps to migrate from G35 to the FY2026 code set.

1. Audit active G35 entries in diagnosis favorites: Pull a list of all providers using G35 as a shortcut in their diagnosis picklist. Coordinate with EHR administrators to deactivate G35 as a direct selection since it is no longer a standalone billable code.
2. Build a structured MS code dropdown: Add all six G35 subcodes to the neurology department’s diagnosis favorites, grouped by disease course. Label each clearly (RRMS, PPMS, SPMS, Unspecified) so clinicians can select the correct code at the point of documentation without knowing the ICD-10-CM number.
3. Update note templates to capture disease course: Add a mandatory or prompted field to MS encounter templates asking the clinician to select the documented disease course. A structured dropdown prevents the “NOS by default” problem that generates G35.D when a specific code was actually supportable.
4. Update claim templates and charge master: Replace G35 with G35.D in all claim templates, charge description master entries, and billing system fee schedule tables. Verify that payer crosswalk tables and LCD/NCD references reflect the FY2026 code set.
5. Train billing and coding staff: Run a focused training session on the FY2026 MS expansion covering when G35.D applies, when to query the provider for a specific subcode, and how to document the query and response per your facility’s query policy.

Practices managing this transition across multiple specialties benefit from a platform that centralizes revenue cycle management, linking EHR documentation directly to claim generation so ICD-10-CM changes propagate without manual intervention in each system separately. Maintaining medical billing compliance through an FY code transition is significantly easier when documentation and billing tools share a live data layer rather than operating as disconnected systems.

The FY2026 retirement of G35 as a standalone code is a documentation challenge as much as a coding one. G35.D captures legitimate unspecified presentations, but it becomes a liability when neurologists have the clinical information to support a more specific code and their EHR templates simply do not prompt them to record it. The practices that will see the fewest denials are those that updated their templates and picklists before October 1, 2025.

Pabau supports neurology billing teams with integrated claims management software that validates ICD-10-CM codes against live payer edits before submission, surfaces ERA data automatically, and flags denial patterns by diagnosis code so teams can trace problems back to documentation gaps. To see how Pabau handles MS coding workflows end to end, book a demo.

Continue your research

Need a broader overview of neurological ICD-10 coding? Intraparenchymal hemorrhage ICD-10 codes covers documentation and sequencing rules for another high-complexity neurological diagnosis code set.

Managing claim denials by ICD-10 code? Denial management in healthcare walks through systematic workflows for tracking, appealing, and reducing payer denials in specialty practices.

Want to understand the billing workflow behind ICD-10-CM submissions? What is revenue cycle management explains how diagnostic codes connect to claim generation, payer adjudication, and payment posting.

Frequently Asked Questions